Log in

Relevant bibliographies by topics / Anti-globulin gel test

Contents

Journal articles

Academic literature on the topic 'Anti-globulin gel test'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-globulin gel test.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-globulin gel test"

1

Cate, John C., and Nancy Reilly. "Evaluation and Implementation of the Gel Test for Indirect Antiglobulin Testing in a Community Hospital Laboratory." Archives of Pathology & Laboratory Medicine 123, no. 8 (1999): 693–97. http://dx.doi.org/10.5858/1999-123-0693-eaiotg.

Full text

Abstract:

Abstract Background.—The gel test, developed by Lapierre in 1984, was designed to standardize antiglobulin testing while improving sensitivity and specificity of the method. Principle.—Anti–human serum immunoglobulin G (IgG) mixed with Sephadex G100 (gel phase) in a microtube traps red cell–IgG agglutination complexes during migration through the gel in a centrifugation step. Agglutination complexes are visibly detectable at various levels in the microtube as an inverse function of antibody coated on red cells. Unsensitized red cells form a cell pellet at the base of the microtube. Objective.—

APA, Harvard, Vancouver, ISO, and other styles

2

Samarah, Fekri, Mahmoud A. Srour, Dirgham Yaseen, and Kamal Dumaidi. "Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine." Advances in Hematology 2018 (June 6, 2018): 1–7. http://dx.doi.org/10.1155/2018/5356245.

Full text

Abstract:

Background. Transfusion of red blood cells (RBC) is an essential therapeutic tool in sickle cell disease (SCD). Repeated RBC transfusions can cause alloimmunization which causes difficulty in cross-matching and finding compatible blood for transfusions. This study aimed to investigate the frequency of RBC alloimmunization and related risk factors among Palestinian SCD patients.Materials and Methods. A multicenter cross-sectional study on 116 previously transfused SCD patients from three centers in West Bank, Palestine. Demographic, medical data and history of transfusion were recorded. Blood s

APA, Harvard, Vancouver, ISO, and other styles

3

Bujandric, Nevenka, Jasmina Grujic, and Zorana Budakov-Obradovic. "Red blood cell alloimmunization in pregnancy: A 10-year single-centre study." Vojnosanitetski pregled, no. 00 (2021): 16. http://dx.doi.org/10.2298/vsp201124016b.

Full text

Abstract:

Background/Aim. Pregnancy-induced red blood cell (RBC) alloimmunization is important not only because of the possible negative effects on subsequent pregnancy outcomes, in case the fetus carries the antigen, but also because of the optimal transfusion management in cases of obstetric haemorrhage. Timely detection of RBC antibodies is part of a testing, prevention and treatment strategy aimed at achieving better outcomes for alloimmunized mothers with an affected fetus. The aim was to determine the frequency and specificity of alloantibodies among pregnant women from the South Backa District, w

APA, Harvard, Vancouver, ISO, and other styles

4

Yurtsever, Nalan, Chris Tormey, Laurie Bizzario, and Edward Lee. "Evaluating RhD Assessment By Automated Methodology: A Potential ‘Blind Spot’ For RhD Variant Identification." American Journal of Clinical Pathology 162, Supplement_1 (2024): S163. http://dx.doi.org/10.1093/ajcp/aqae129.360.

Full text

Abstract:

Abstract Background Automated blood typing platforms are ideal for blood donor centers, given their broad recognition of RhD antigen variants, resulting in products from such donors to be labeled as RhD positive. However, this ‘blind spot’ for variants may be problematic for hospital-based transfusion services, since RhD variants may require provision of RhD- RBC units and Rh immune globulin. The extent to which automated methods accurately characterize variant D antigen expression is not known. As such, the objective of our study was to assess D typing results, as well as RHD genotyping, amon

APA, Harvard, Vancouver, ISO, and other styles

5

Lee, Oukseub, Xinlei Mi, Yanfei Xu, et al. "Abstract PD15-12: PD15-12 A pre-surgical window trial of oral tamoxifen versus transdermal 4-hydroxytamoxifen gel in women with estrogen receptor positive duct carcinoma in situ (DCIS)." Cancer Research 83, no. 5_Supplement (2023): PD15–12—PD15–12. http://dx.doi.org/10.1158/1538-7445.sabcs22-pd15-12.

Full text

Abstract:

Abstract Background: Adjuvant oral tamoxifen (TAM) benefits women with DCIS, but toxicity concerns have limited its acceptance. Transdermal therapy with 4-hydroxy tamoxifen (4-OHT) gel applied to the breast skin is a possible solution. Previous pilot data suggest equivalent anti-proliferative efficacy of TAM and 4-OHT gel, but minimal systemic exposure with transdermal therapy. We report a prospective double blinded randomized phase 2 trial comparing TAM to 4-OHT gel in women with DCIS. Methods: 107 women with estrogen receptor positive (≥10%) DCIS were randomized to TAM (20 mg/day + placebo g

APA, Harvard, Vancouver, ISO, and other styles

6

Jain, Ashish, Sharanya Ramakrishnan, Parmatma Prasad Tripathi, Rekha Hans, Deepak Bansal, and Ratti Ram Sharma. "Transfusion management in a pediatric patient with febrile neutropenia with red blood cell autoantibodies: a case report." International Journal of Research in Medical Sciences 9, no. 12 (2021): 3696. http://dx.doi.org/10.18203/2320-6012.ijrms20214722.

Full text

Abstract:

Febrile neutropenia is a common complication of chemotherapy especially in hematological malignancies associated with sepsis or severe infection. We report a case where a seven-year-old girl with T – cell acute lymphoblastic leukemia (ALL) developed febrile neutropenia (absolute neutrophil count - ANC <500/µL). Patient developed transient red blood cell (RBC) autoantibodies which interfered with compatibility testing and posed a challenge in donor selection for granulocyte transfusion. Direct antiglobulin test (DAT) and compatibility testing were done by column agglutination technique (CAT)

APA, Harvard, Vancouver, ISO, and other styles

7

Lee, Oukseub, Latifa Bazzi, Yanfei Xu, et al. "Abstract RF01-02: A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: evaluation of dermal safety, intra-mammary drug distribution, and biologic effects." Cancer Research 84, no. 9_Supplement (2024): RF01–02—RF01–02. http://dx.doi.org/10.1158/1538-7445.sabcs23-rf01-02.

Full text

Abstract:

Abstract Background: Breast cancer prevention requires only local exposure of the breast to active drug but oral preventive agents entail systemic exposure, with resultant adverse effects, limiting acceptance by high-risk women. Drug-delivery through the breast skin is an attractive option, but requires demonstration of dermal safety and drug distribution throughout the breast. We formulated the tamoxifen metabolite (E/Z)-endoxifen in a hydroalcoholic/oleic acid gel for transdermal delivery. We tested this in a placebo-controlled, double-blinded Phase I trial with dose escalation from 10 to 20

APA, Harvard, Vancouver, ISO, and other styles

8

Thant, Mamie Myo, and Alesia Kaplan. "The Impact of the "Super Coombs" Test on Patient Management and Outcomes at a Large Tertiary Care Center: A Retrospective Review." Blood 138, Supplement 1 (2021): 1073. http://dx.doi.org/10.1182/blood-2021-149287.

Full text

Abstract:

Abstract Background: The direct antiglobulin test (DAT) identifies the presence of immunoglobulins and complement on the surface of red blood cells and is used to differentiate immune from non-immune hemolysis. Standard DATs done by conventional methods, using anti-IgG or anti-C3 antihuman globulin (AHG) in tube or gel, are performed routinely by laboratories associated with hospital transfusion services. However, if the standard DAT is negative but a strong clinical suspicion for immune-mediated hemolysis remains, serologic testing at an immunohematology reference lab (IRL) can be performed.

APA, Harvard, Vancouver, ISO, and other styles

9

Chari, Ajai, Toshihisa Satta, Amit Tayal, et al. "Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab." Blood 126, no. 23 (2015): 3571. http://dx.doi.org/10.1182/blood.v126.23.3571.3571.

Full text

Abstract:

Abstract Background Daratumumab (DARA) is a human IgG1 kappa monoclonal antibody that targets cells expressing CD38, which is highly expressed in multiple myeloma (MM) cells. In the phase 2 MMY2002 (Sirius) trial, treatment with single agent DARA resulted in a 29% overall response rate, with a median PFS of 3.7 months in heavily pretreated MM patients (Lonial S. J Clin Oncol. 2015; 33(suppl): abstrLBA8512). However, CD38 is also expressed on red blood cells (RBCs) and DARA binding to RBCs results in pan-reactivity on RBC panel testing using an indirect antiglobulin test (IAT). Recently, it was

APA, Harvard, Vancouver, ISO, and other styles

10

Vaillant, Angel Alberto Justiz, Patrick Eberechi Akpaka, Norma Mc Farlane-Anderson, and Monica P. Smikle. "Use of Staphylococcal Protein-A and Streptococcal Protein-G for Detection of Red Blood Cells (RBC) Antibodies and Comparison with Other Techniques." May 24, 2013. https://doi.org/10.5281/zenodo.8003.

Full text

Abstract:

Background: Detection of red blood cells antibodies is important for the diagnosis of autoimmune hemolytic anemia, hemolytic disease of newborn, pre-transfusion testing and other problems. The aim of this study was to use Staphylococcal protein A (SpA) and Streptococcal protein G (SpG) as reagents in immunological tests for detecting red blood cells (RBC) antibodies and to compare the method with other techniques. Study Design & Methods: Sera from 60 patients, comprising forty-four anti-D positive sera from pregnant women and 16 from healthy controls were, used for the study. The anti-glob

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!